Age: 41.0
Sex: F
Vaccine: PPV, PPV, PPV
Symptoms: Loss of personal independence in daily activities, Mobility decreased, Pain in extremity, Peripheral swelling
Clinical narrative: swelling and pain in the arm in which the PNEUMOVAX 23 was administered; having trouble moving her arm, requiring assistance from her husband with AD L's; assistance from her husband with AD L's; swelling and pain in the arm in which the PNEUMOVAX 23 was administered; the PNEUMOVAX 23 was inadvertently administered into the vein rather than the deltoid muscle; the PNEUMOVAX 23 was inadvertently administered into the vein rather than the deltoid muscle; unspecified pneumococcal vaccine only two years prior; This spontaneous report was received from a pharmacist refers to a 43-year-old female patient. Concomitant therapies included prednisone, muscle relaxers (as needed) and influenza virus vaccine. The patient's pertinent medical history included multiple sclerosis. The patient's drug reactions/ allergies included penicillin. In October 2010 (only two years prior), the patient did receive an unspecified pneumococcal vaccine (manufacturer unknown).  On 17-OCT-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # T020638, expiration date reported as February 2022, upon internal validation established as 26-FEB-2022, 0.5 milliliter, intramuscular in the deltoid) for prophylaxis.    On 17-OCT-2020, the patient began to have swelling and pain in the arm in which the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was administered. It was reported that on 19-OCT-2020, the patient made contact via phone with her primary care physician as the swelling and pain continued in the arm that the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was administered, as well as having trouble moving her arm, requiring assistance from her husband with AD L's. Physician directed patient to "up" her dose of prednisone, take her muscle relaxant and use ibuprofen. Physician was concerned that the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was inadvertently administered into the vein rather than the deltoid muscle and that the patient may need to follow up with a neurologist (inappropriate schedule of product administration, incorrect route of product administration, product administered at inappropriate site). Pharmacist noted that at this time, but the pain was still continued, the other events were recovering. The causality assessment was not reported.  The events were considered to be significant disability or incapacity by reporter.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: devicelotnumber: T020638; expirationdate: 26-FEB-2022; deviceage and unit: 0 ; malfunction: Unknown; productavailableforevaluation: No; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent; Sender's Comments:  US-009507513-2011USA002618: